학술논문

Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017.
Document Type
article
Source
Eurosurveillance. 22(43)
Subject
Australia
epidemiology
influenza
influenza-like illness - ILI
surveillance
vaccines and immunisation
viral infections
Adolescent
Adult
Aged
Aged
80 and over
Australia
Child
Child
Preschool
Female
Humans
Influenza A Virus
H1N1 Subtype
Influenza A Virus
H3N2 Subtype
Influenza B virus
Influenza Vaccines
Influenza
Human
Laboratories
Male
Middle Aged
Outcome Assessment
Health Care
RNA
Viral
Seasons
Sentinel Surveillance
Sequence Analysis
DNA
Vaccination
Vaccine Potency
Vaccines
Inactivated
Young Adult
Language
Abstract
In 2017, influenza seasonal activity was high in the southern hemisphere. We present interim influenza vaccine effectiveness (VE) estimates from Australia. Adjusted VE was low overall at 33% (95% confidence interval (CI): 17 to 46), 50% (95% CI: 8 to 74) for A(H1)pdm09, 10% (95% CI: -16 to 31) for A(H3) and 57% (95% CI: 41 to 69) for influenza B. For A(H3), VE was poorer for those vaccinated in the current and prior seasons.